{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:01Z","timestamp":1792791541418,"version":"4.5.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-BS-107"],"award-info":[{"award-number":["2023-BS-107"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-03086-z","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:34:10Z","timestamp":1737020050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Organoid development and applications in gynecological cancers: the new stage of tumor treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"4","key":"3086_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/jcm12041480","volume":"12","author":"JJ Sznurkowski","year":"2023","unstructured":"Sznurkowski JJ, Rys J, Kowalik A, Zolciak-Siwinska A, Bodnar L, Chudecka-Glaz A, et al. The Polish society of gynecological oncology guidelines for the diagnosis and treatment of endometrial carcinoma. J Clin Med. 2023;12(4):1480.","journal-title":"J Clin Med"},{"issue":"2","key":"3086_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.23.01771","volume":"42","author":"J St Laurent","year":"2024","unstructured":"St Laurent J, Liu JF. Treatment approaches for platinum-resistant ovarian cancer. J Clin Oncol. 2024;42(2):127\u201333.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3086_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","volume":"35","author":"G Bogani","year":"2024","unstructured":"Bogani G, Monk BJ, Powell MA, Westin SN, Slomovitz B, Moore KN, et al. Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer. Ann Oncol. 2024;35(5):414\u201328.","journal-title":"Ann Oncol"},{"key":"3086_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcancer.2023.10.002","volume":"96","author":"N Godbole","year":"2023","unstructured":"Godbole N, Quinn A, Carrion F, Pelosi E, Salomon C. Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer. Semin Cancer Biol. 2023;96:64\u201381.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"3086_CR5","first-page":"561","volume":"91","author":"SM Penny","year":"2020","unstructured":"Penny SM. Ovarian cancer: an overview. Radiol Technol. 2020;91(6):561\u201375.","journal-title":"Radiol Technol"},{"issue":"3","key":"3086_CR6","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2666-5247(23)00257-4","volume":"5","author":"A Mitra","year":"2024","unstructured":"Mitra A, Gultekin M, Burney Ellis L, Bizzarri N, Bowden S, Taumberger N, et al. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement. Lancet Microbe. 2024;5(3):e291\u2013300.","journal-title":"Lancet Microbe"},{"issue":"1","key":"3086_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174013","volume":"134","author":"Y Wang","year":"2024","unstructured":"Wang Y, Duval AJ, Adli M, Matei D. Biology-driven therapy advances in high-grade serous ovarian cancer. J Clin Invest. 2024;134(1): e174013.","journal-title":"J Clin Invest"},{"issue":"15","key":"3086_CR8","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40265-023-01934-0","volume":"83","author":"V Garg","year":"2023","unstructured":"Garg V, Oza AM. Treatment of ovarian cancer beyond PARP inhibition: current and future options. Drugs. 2023;83(15):1365\u201385.","journal-title":"Drugs"},{"issue":"10333","key":"3086_CR9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412\u201328.","journal-title":"Lancet"},{"issue":"2","key":"3086_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mcna.2022.10.006","volume":"107","author":"K Gavinski","year":"2023","unstructured":"Gavinski K, DiNardo D. Cervical cancer screening. Med Clin North Am. 2023;107(2):259\u201369.","journal-title":"Med Clin North Am"},{"key":"3086_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108526","volume":"251","author":"DK Dey","year":"2023","unstructured":"Dey DK, Krause D, Rai R, Choudhary S, Dockery LE, Chandra V. The role and participation of immune cells in the endometrial tumor microenvironment. Pharmacol Ther. 2023;251: 108526.","journal-title":"Pharmacol Ther"},{"key":"3086_CR12","doi-asserted-by":"publisher","first-page":"1167088","DOI":"10.3389\/fonc.2023.1167088","volume":"13","author":"F Perelli","year":"2023","unstructured":"Perelli F, Mattei A, Scambia G, Cavaliere AF. Editorial: Methods in gynecological oncology. Front Oncol. 2023;13:1167088.","journal-title":"Front Oncol"},{"key":"3086_CR13","doi-asserted-by":"publisher","first-page":"1220467","DOI":"10.3389\/fonc.2023.1220467","volume":"13","author":"M Virarkar","year":"2023","unstructured":"Virarkar M, Bhosale PR. Editorial: women in gynecological oncology 2021. Front Oncol. 2023;13:1220467.","journal-title":"Front Oncol"},{"issue":"10","key":"3086_CR14","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.ejso.2022.06.020","volume":"48","author":"N Baldewpersad Tewarie","year":"2022","unstructured":"Baldewpersad Tewarie N, van Driel WJ, van Ham M, Wouters MW, Rome RM, H\u00f8gdall CK, et al. An overview of clinical quality registries (CQRs) on gynecological oncology worldwide. Eur J Surg Oncol. 2022;48(10):2094\u2013103.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3086_CR15","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corr\u00f2","year":"2020","unstructured":"Corr\u00f2 C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151-c165.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3086_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","volume":"2","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L, et al. Organoids. Nat Rev Methods Primers. 2022;2:94.","journal-title":"Nat Rev Methods Primers"},{"key":"3086_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2019.122456","volume":"297","author":"W Li","year":"2020","unstructured":"Li W, Liu Y, Hou Q, Huang W, Zheng H, Gao X, et al. Lactobacillus plantarum improves the efficiency of sheep manure composting and the quality of the final product. Bioresour Technol. 2020;297: 122456.","journal-title":"Bioresour Technol"},{"issue":"3","key":"3086_CR18","first-page":"132","volume":"17","author":"A Fenner","year":"2020","unstructured":"Fenner A. Genomic profiling suggests possible immunotherapy response in rare subtypes. Nat Rev Urol. 2020;17(3):132.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"3086_CR19","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/ibd\/izy062","volume":"24","author":"R Izzo","year":"2018","unstructured":"Izzo R, Bevivino G, De Simone V, Sedda S, Monteleone I, Marafini I, et al. Knockdown of Smad7 with a specific antisense oligonucleotide attenuates colitis and colitis-driven colonic fibrosis in mice. Inflamm Bowel Dis. 2018;24(6):1213\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"13-S","key":"3086_CR20","volume":"91","author":"Z Naureen","year":"2020","unstructured":"Naureen Z, Lorusso L, Manganotti P, Caruso P, Mazzon G, Cecchin S, et al. Genetics of pain: From rare Mendelian disorders to genetic predisposition to pain. Acta Biomed. 2020;91(13-S): e2020010.","journal-title":"Acta Biomed"},{"issue":"11","key":"3086_CR21","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3390\/ma13112534","volume":"13","author":"EA Flores-Johnson","year":"2020","unstructured":"Flores-Johnson EA, Company-Rodriguez BA, Koh-Dzul JF, Carrillo JG. Shaking table test of U-shaped walls made of fiber-reinforced foamed concrete. Materials (Basel, Switzerland). 2020;13(11):2534.","journal-title":"Materials (Basel, Switzerland)"},{"issue":"2","key":"3086_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143\u201359.","journal-title":"Nat Mater"},{"issue":"3","key":"3086_CR23","first-page":"e274","volume":"4","author":"S Yang","year":"2023","unstructured":"Yang S, Hu H, Kung H, Zou R, Dai Y, Hu Y, et al. Organoids: the current status and biomedical applications. Med Comm. 2023;4(3):e274.","journal-title":"Med Comm"},{"issue":"4","key":"3086_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00109-020-02028-0","volume":"99","author":"C Chumduri","year":"2021","unstructured":"Chumduri C, Turco MY. Organoids of the female reproductive tract. J Mol Med (Berl). 2021;99(4):531\u201353.","journal-title":"J Mol Med (Berl)"},{"key":"3086_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.placenta.2020.08.017","volume":"101","author":"M Marini\u0107","year":"2020","unstructured":"Marini\u0107 M, Rana S, Lynch VJ. Derivation of endometrial gland organoids from term placenta. Placenta. 2020;101:75\u20139.","journal-title":"Placenta"},{"key":"3086_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121213","volume":"279","author":"X Li","year":"2021","unstructured":"Li X, Zheng M, Xu B, Li D, Shen Y, Nie Y, et al. Generation of offspring-producing 3D ovarian organoids derived from female germline stem cells and their application in toxicological detection. Biomaterials. 2021;279: 121213.","journal-title":"Biomaterials"},{"issue":"10","key":"3086_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1242\/dev.148478","volume":"144","author":"M Boretto","year":"2017","unstructured":"Boretto M, Cox B, Noben M, Hendriks N, Fassbender A, Roose H, et al. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development. 2017;144(10):1775\u201386.","journal-title":"Development"},{"key":"3086_CR28","first-page":"10","volume":"191","author":"S Tang","year":"2023","unstructured":"Tang S, Parks SE, Liao Z, Cope DI, Blutt SE, Monsivais D. Establishing 3D endometrial organoids from the mouse uterus. J Vis Exp. 2023;191:10.","journal-title":"J Vis Exp"},{"issue":"8","key":"3086_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","volume":"21","author":"M Boretto","year":"2019","unstructured":"Boretto M, Maenhoudt N, Luo X, Hennes A, Boeckx B, Bui B, et al. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nat Cell Biol. 2019;21(8):1041\u201351.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"3086_CR30","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1210\/en.2019-00314","volume":"160","author":"S Haider","year":"2019","unstructured":"Haider S, Gamperl M, Burkard TR, Kunihs V, Kaindl U, Junttila S, et al. Estrogen signaling drives ciliogenesis in human endometrial organoids. Endocrinology. 2019;160(10):2282\u201397.","journal-title":"Endocrinology"},{"issue":"4","key":"3086_CR31","doi-asserted-by":"publisher","first-page":"gaad007","DOI":"10.1093\/molehr\/gaad007","volume":"29","author":"HC Fitzgerald","year":"2023","unstructured":"Fitzgerald HC, Kelleher AM, Ranjit C, Schust DJ, Spencer TE. Basolateral secretions of human endometrial epithelial organoids impact stromal cell decidualization. Mol Hum Reprod. 2023;29(4):gaad007.","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"3086_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100526","volume":"22","author":"Y Dong","year":"2023","unstructured":"Dong Y, Li J, Cao D, Zhong J, Liu X, Duan YG, et al. Integrated microRNA and secretome analysis of human endometrial organoids reveal the miR-3194-5p\/aquaporin\/S100A9 module in regulating trophoblast functions. Mol Cell Proteom. 2023;22(4): 100526.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"3086_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/jpm11121314","volume":"11","author":"CE Filby","year":"2021","unstructured":"Filby CE, Wyatt KA, Mortlock S, Cousins FL, McKinnon B, Tyson KE, et al. Comparison of organoids from menstrual fluid and hormone-treated endometrium: novel tools for gynecological research. J Pers Med. 2021;11(12):1314.","journal-title":"J Pers Med"},{"issue":"46","key":"3086_CR34","doi-asserted-by":"publisher","first-page":"23132","DOI":"10.1073\/pnas.1915389116","volume":"116","author":"HC Fitzgerald","year":"2019","unstructured":"Fitzgerald HC, Dhakal P, Behura SK, Schust DJ, Spencer TE. Self-renewing endometrial epithelial organoids of the human uterus. Proc Natl Acad Sci USA. 2019;116(46):23132\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3086_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2023.108522","volume":"123","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen W, Dong X, Shang W, Shao S, Zhang L. Long-term maintenance of human endometrial epithelial organoids and their stem cell properties. Reprod Toxicol. 2024;123: 108522.","journal-title":"Reprod Toxicol"},{"issue":"11","key":"3086_CR36","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cells11111760","volume":"11","author":"SC Hewitt","year":"2022","unstructured":"Hewitt SC, Wu SP, Wang T, Young SL, Spencer TE, DeMayo FJ. Progesterone signaling in endometrial epithelial organoids. Cells. 2022;11(11):1760.","journal-title":"Cells"},{"issue":"2","key":"3086_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/path.5511","volume":"252","author":"DR Cochrane","year":"2020","unstructured":"Cochrane DR, Campbell KR, Greening K, Ho GC, Hopkins J, Bui M, et al. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours. J Pathol. 2020;252(2):201\u201314.","journal-title":"J Pathol"},{"issue":"9","key":"3086_CR38","doi-asserted-by":"publisher","first-page":"bqac116","DOI":"10.1210\/endocr\/bqac116","volume":"163","author":"SC Hewitt","year":"2022","unstructured":"Hewitt SC, Wu SP, Wang T, Ray M, Brolinson M, Young SL, et al. The estrogen receptor \u03b1 Cistrome in human endometrium and epithelial organoids. Endocrinology. 2022;163(9):bqac116.","journal-title":"Endocrinology"},{"issue":"1","key":"3086_CR39","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1038\/s41467-023-40701-3","volume":"14","author":"MH Geurts","year":"2023","unstructured":"Geurts MH, Gandhi S, Boretto MG, Akkerman N, Derks LLM, van Son G, et al. One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids. Nat Commun. 2023;14(1):4998.","journal-title":"Nat Commun"},{"issue":"6","key":"3086_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-021-00337-8","volume":"10","author":"Y Maru","year":"2021","unstructured":"Maru Y, Tanaka N, Tatsumi Y, Nakamura Y, Itami M, Hippo Y. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition. Oncogenesis. 2021;10(6):46.","journal-title":"Oncogenesis"},{"issue":"2","key":"3086_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/path.5752","volume":"255","author":"Y Maru","year":"2021","unstructured":"Maru Y, Tanaka N, Tatsumi Y, Nakamura Y, Yao R, Noda T, et al. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids. J Pathol. 2021;255(2):177\u201389.","journal-title":"J Pathol"},{"issue":"1","key":"3086_CR42","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","volume":"11","author":"K L\u00f5hmussaar","year":"2020","unstructured":"L\u00f5hmussaar K, Kopper O, Korving J, Begthel H, Vreuls CPH, van Es JH, et al. Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. Nat Commun. 2020;11(1):2660.","journal-title":"Nat Commun"},{"issue":"3","key":"3086_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.rbmo.2020.03.019","volume":"41","author":"BN Bui","year":"2020","unstructured":"Bui BN, Boretto M, Kobayashi H, van Hoesel M, Steba GS, van Hoogenhuijze N, et al. Organoids can be established reliably from cryopreserved biopsy catheter-derived endometrial tissue of infertile women. Reprod Biomed Online. 2020;41(3):465\u201373.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"3086_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1210\/clinem\/dgz100","volume":"105","author":"T Wiwatpanit","year":"2020","unstructured":"Wiwatpanit T, Murphy AR, Lu Z, Urbanek M, Burdette JE, Woodruff TK, et al. Scaffold-free endometrial organoids respond to excess androgens associated with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2020;105(3):769\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"3086_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115344","volume":"210","author":"C Xu","year":"2024","unstructured":"Xu C, Alameri A, Leong W, Johnson E, Chen Z, Xu B, et al. Multiscale engineering of brain organoids for disease modeling. Adv Drug Deliv Rev. 2024;210: 115344.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3086_CR46","volume":"5","author":"X Han","year":"2024","unstructured":"Han X, Cai C, Deng W, Shi Y, Li L, Wang C, et al. Landscape of human organoids: Ideal model in clinics and research. Innovation (Camb). 2024;5(3): 100620.","journal-title":"Innovation (Camb)"},{"key":"3086_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115238","volume":"208","author":"S Park","year":"2024","unstructured":"Park S, Cho SW. Bioengineering toolkits for potentiating organoid therapeutics. Adv Drug Deliv Rev. 2024;208: 115238.","journal-title":"Adv Drug Deliv Rev"},{"key":"3086_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115237","volume":"208","author":"S Maharjan","year":"2024","unstructured":"Maharjan S, Ma C, Singh B, Kang H, Orive G, Yao J, et al. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications. Adv Drug Deliv Rev. 2024;208: 115237.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3086_CR49","doi-asserted-by":"publisher","first-page":"788","DOI":"10.7150\/thno.90492","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Ning X, Zhao F, Zhao H, Li D. Human organoids-on-chips for biomedical research and applications. Theranostics. 2024;14(2):788\u2013818.","journal-title":"Theranostics"},{"key":"3086_CR50","doi-asserted-by":"publisher","first-page":"115142","DOI":"10.1016\/j.addr.2023.115142","volume":"203","author":"N Roberto de Barros","year":"2023","unstructured":"Roberto de Barros N, Wang C, Maity S, Peirsman A, Nasiri R, Herland A, et al. Engineered organoids for biomedical applications. Adv Drug Deliv Rev. 2023;203:115142.","journal-title":"Adv Drug Deliv Rev"},{"key":"3086_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115081","volume":"201","author":"M Barroso","year":"2023","unstructured":"Barroso M, Monaghan MG, Niesner R, Dmitriev RI. Probing organoid metabolism using fluorescence lifetime imaging microscopy (FLIM): the next frontier of drug discovery and disease understanding. Adv Drug Deliv Rev. 2023;201: 115081.","journal-title":"Adv Drug Deliv Rev"},{"issue":"26","key":"3086_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300903","volume":"12","author":"N Landon-Brace","year":"2023","unstructured":"Landon-Brace N, Li NT, McGuigan AP. Exploring new dimensions of tumor heterogeneity: the application of single cell analysis to organoid-based 3D in vitro models. Adv Healthc Mater. 2023;12(26): e2300903.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"3086_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302506","volume":"20","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li G, Wang J, Zhou F, Ren X, Su J. Small joint organoids 3D bioprinting: construction strategy and application. Small. 2024;20(8): e2302506.","journal-title":"Small"},{"issue":"20","key":"3086_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203256","volume":"12","author":"H Kutluk","year":"2023","unstructured":"Kutluk H, Bastounis EE, Constantinou I. Integration of extracellular matrices into organ-on-chip systems. Adv Healthc Mater. 2023;12(20): e2203256.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"3086_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12951-022-01717-x","volume":"20","author":"Y Chien","year":"2022","unstructured":"Chien Y, Hsiao YJ, Chou SJ, Lin TY, Yarmishyn AA, Lai WY, et al. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities. J Nanobiotechnology. 2022;20(1):511.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"3086_CR56","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41596-021-00669-0","volume":"17","author":"SC Lin","year":"2022","unstructured":"Lin SC, Haga K, Zeng XL, Estes MK. Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning. Nat Protoc. 2022;17(4):1004\u201327.","journal-title":"Nat Protoc"},{"issue":"12","key":"3086_CR57","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cac2.12224","volume":"41","author":"J Qu","year":"2021","unstructured":"Qu J, Kalyani FS, Liu L, Cheng T, Chen L. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy. Cancer Commun (Lond). 2021;41(12):1331\u201353.","journal-title":"Cancer Commun (Lond)"},{"key":"3086_CR58","doi-asserted-by":"publisher","first-page":"963689723121840","DOI":"10.1177\/09636897231218408","volume":"32","author":"Y Xu","year":"2023","unstructured":"Xu Y, Cai S, Wang Q, Cheng M, Hui X, Dzakah EE, et al. Multi-lineage human endometrial organoids on acellular amniotic membrane for endometrium regeneration. Cell Transplant. 2023;32:9636897231218408.","journal-title":"Cell Transplant"},{"issue":"1","key":"3086_CR59","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41598-018-38376-8","volume":"9","author":"A Hennes","year":"2019","unstructured":"Hennes A, Held K, Boretto M, De Clercq K, Van den Eynde C, Vanhie A, et al. Functional expression of the mechanosensitive PIEZO1 channel in primary endometrial epithelial cells and endometrial organoids. Sci Rep. 2019;9(1):1779.","journal-title":"Sci Rep"},{"issue":"8","key":"3086_CR60","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","volume":"28","author":"K L\u00f5hmussaar","year":"2021","unstructured":"L\u00f5hmussaar K, Oka R, Espejo Valle-Inclan J, Smits MHH, Wardak H, Korving J, et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell. 2021;28(8):1380-1396.e1386.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3086_CR61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4149\/neo_2022_211110N1597","volume":"69","author":"YL Wu","year":"2022","unstructured":"Wu YL, Li JQ, Sulaiman Z, Liu Q, Wang CY, Liu SP, et al. Optimization of endometrial cancer organoids establishment by cancer-associated fibroblasts. Neoplasma. 2022;69(4):877\u201385.","journal-title":"Neoplasma"},{"key":"3086_CR62","doi-asserted-by":"publisher","first-page":"1059228","DOI":"10.3389\/fendo.2023.1059228","volume":"14","author":"A Katcher","year":"2023","unstructured":"Katcher A, Yueh B, Ozler K, Nizam A, Kredentser A, Chung C, et al. Establishing patient-derived organoids from human endometrial cancer and normal endometrium. Front Endocrinol (Lausanne). 2023;14:1059228.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"3086_CR63","doi-asserted-by":"publisher","first-page":"108198","DOI":"10.1016\/j.isci.2023.108198","volume":"26","author":"H Huang","year":"2023","unstructured":"Huang H, Pan Y, Huang J, Zhang C, Liao Y, Du Q, et al. Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer. iScience. 2023;26(11):108198.","journal-title":"iScience"},{"issue":"12","key":"3086_CR64","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","volume":"58","author":"W Senkowski","year":"2023","unstructured":"Senkowski W, Gall-Mas L, Falco MM, Li Y, Lavikka K, Kriegbaum MC, et al. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. Dev Cell. 2023;58(12):1106-1121.e1107.","journal-title":"Dev Cell"},{"issue":"1","key":"3086_CR65","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13046-023-02809-8","volume":"42","author":"L Thorel","year":"2023","unstructured":"Thorel L, Morice PM, Paysant H, Florent R, Babin G, Thomine C, et al. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma. J Exp Clin Cancer Res. 2023;42(1):260.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3086_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2019.05.005","volume":"154","author":"Y Maru","year":"2019","unstructured":"Maru Y, Tanaka N, Itami M, Hippo Y. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. Gynecol Oncol. 2019;154(1):189\u201398.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3086_CR67","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1186\/s12885-022-10042-3","volume":"22","author":"YA Chen","year":"2022","unstructured":"Chen YA, Lu CY, Cheng WF, Kuo KT, Yu CW, Ho HN, et al. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids. BMC Cancer. 2022;22(1):967.","journal-title":"BMC Cancer"},{"key":"3086_CR68","first-page":"10","volume":"191","author":"O Graham","year":"2023","unstructured":"Graham O, Rodriguez J, van Biljon L, Fashemi B, Graham E, Fuh K, et al. Generation and culturing of high-grade serous ovarian cancer patient-derived organoids. J Vis Exp. 2023;191:10.","journal-title":"J Vis Exp"},{"issue":"6","key":"3086_CR69","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104013","volume":"39","author":"K Hoffmann","year":"2020","unstructured":"Hoffmann K, Berger H, Kulbe H, Thillainadarasan S, Mollenkopf HJ, Zemojtel T, et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment. Embo j. 2020;39(6): e104013.","journal-title":"Embo j"},{"key":"3086_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83867","volume":"12","author":"M Vias","year":"2023","unstructured":"Vias M, Morrill Gavarr\u00f3 L, Sauer CM, Sanders DA, Piskorz AM, Couturier DL, et al. High-grade serous ovarian carcinoma organoids as models of chromosomal instability. Elife. 2023;12: e83867.","journal-title":"Elife"},{"issue":"1","key":"3086_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13046-023-02801-2","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen X, Liu X, Li QH, Lu BF, Xie BM, Ji YM, et al. A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 expression and \u03b2-catenin nuclear accumulation. J Exp Clin Cancer Res. 2023;42(1):230.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"3086_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12274","volume":"42","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen W, Zuo L, Xu M, Wu Y, Huang J, et al. The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun (Lond). 2022;42(3):245\u201365.","journal-title":"Cancer Commun (Lond)"},{"issue":"15","key":"3086_CR73","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.7150\/thno.43811","volume":"10","author":"H Sun","year":"2020","unstructured":"Sun H, Wang H, Wang X, Aoki Y, Wang X, Yang Y, et al. Aurora-A\/SOX8\/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics. 2020;10(15):6928\u201345.","journal-title":"Theranostics"},{"issue":"22","key":"3086_CR74","doi-asserted-by":"publisher","first-page":"14173","DOI":"10.3390\/ijms232214173","volume":"23","author":"J Hoarau-V\u00e9chot","year":"2022","unstructured":"Hoarau-V\u00e9chot J, Blot-Dupin M, Pauly L, Touboul C, Rafii S, Rafii A, et al. Akt-activated endothelium increases cancer cell proliferation and resistance to treatment in ovarian cancer cell organoids. Int J Mol Sci. 2022;23(22):14173.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3086_CR75","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/ijms25020886","volume":"25","author":"Y Dai","year":"2024","unstructured":"Dai Y, Xu J, Gong X, Wei J, Gao Y, Chai R, et al. Human fallopian tube-derived organoids with TP53 and RAD51D mutations recapitulate an early stage high-grade serous ovarian cancer phenotype in vitro. Int J Mol Sci. 2024;25(2):886.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3086_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12935-024-03228-1","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang Y, Miao H, Xu T, Nie X, Cheng W. CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids. Cancer Cell Int. 2024;24(1):42.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"3086_CR77","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/1535-7163.MCT-19-0510","volume":"19","author":"M Vernon","year":"2020","unstructured":"Vernon M, Lambert B, Meryet-Figui\u00e8re M, Brotin E, Weiswald LB, Paysant H, et al. Functional miRNA screening identifies wide-ranging antitumor properties of miR-3622b-5p and reveals a new therapeutic combination strategy in ovarian tumor organoids. Mol Cancer Ther. 2020;19(7):1506\u201319.","journal-title":"Mol Cancer Ther"},{"key":"3086_CR78","doi-asserted-by":"publisher","first-page":"1291559","DOI":"10.3389\/fonc.2023.1291559","volume":"13","author":"X Cai","year":"2023","unstructured":"Cai X, Li Y, Zheng J, Liu L, Jiao Z, Lin J, et al. Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids. Front Oncol. 2023;13:1291559.","journal-title":"Front Oncol"},{"key":"3086_CR79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbrc.2022.11.063","volume":"638","author":"Y Wan","year":"2023","unstructured":"Wan Y, Zhang Y, Meng H, Miao H, Jiang Y, Zhang L, et al. Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovarian borderline tumor organoids. Biochem Biophys Res Commun. 2023;638:76\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"3086_CR80","doi-asserted-by":"publisher","first-page":"1368592","DOI":"10.3389\/fonc.2024.1368592","volume":"14","author":"MJ Dahl","year":"2024","unstructured":"Dahl MJ, Lofgren KA, Haugen C, Harmon GE, Hughes SP, Cowden Dahl KD. Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids. Front Oncol. 2024;14:1368592.","journal-title":"Front Oncol"},{"issue":"3","key":"3086_CR81","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s13577-024-01048-z","volume":"37","author":"Y Maru","year":"2024","unstructured":"Maru Y, Kohno M, Suzuka K, Odaka A, Masuda M, Araki A, et al. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer. Hum Cell. 2024;37(3):840\u201353.","journal-title":"Hum Cell"},{"issue":"9","key":"3086_CR82","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1111\/cas.14119","volume":"110","author":"Y Maru","year":"2019","unstructured":"Maru Y, Tanaka N, Ebisawa K, Odaka A, Sugiyama T, Itami M, et al. Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma. Cancer Sci. 2019;110(9):2992\u20133005.","journal-title":"Cancer Sci"},{"issue":"3","key":"3086_CR83","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e35","volume":"34","author":"HS Seol","year":"2023","unstructured":"Seol HS, Oh JH, Choi E, Kim S, Kim H, Nam EJ. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine. J Gynecol Oncol. 2023;34(3): e35.","journal-title":"J Gynecol Oncol"},{"key":"3086_CR84","doi-asserted-by":"publisher","first-page":"1178316","DOI":"10.3389\/fcell.2023.1178316","volume":"11","author":"R Di Fonte","year":"2023","unstructured":"Di Fonte R, Strippoli S, Garofoli M, Cormio G, Serrat\u00ec S, Loizzi V, et al. Cervical cancer benefits from trabectedin combination with the \u03b2-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids. Front Cell Dev Biol. 2023;11:1178316.","journal-title":"Front Cell Dev Biol"},{"issue":"1\u20132","key":"3086_CR85","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41417-020-0190-y","volume":"28","author":"J Chen","year":"2021","unstructured":"Chen J, Zhao L, Peng H, Dai S, Quan Y, Wang M, et al. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway. Cancer Gene Ther. 2021;28(1\u20132):112\u201325.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"3086_CR86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41698-023-00478-6","volume":"7","author":"AT Sengal","year":"2023","unstructured":"Sengal AT, Bonazzi V, Smith D, Moiola CP, Lourie R, Rogers R, et al. Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition. NPJ Precis Oncol. 2023;7(1):127.","journal-title":"NPJ Precis Oncol"},{"issue":"8","key":"3086_CR87","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/IGC.0000000000001061","volume":"27","author":"E Girda","year":"2017","unstructured":"Girda E, Huang EC, Leiserowitz GS, Smith LH. The use of endometrial cancer patient-derived organoid culture for drug sensitivity testing is feasible. Int J Gynecol Cancer. 2017;27(8):1701\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"3086_CR88","first-page":"3357","volume":"22","author":"HH Zhang","year":"2018","unstructured":"Zhang HH, Li AH. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer. Eur Rev Med Pharmacol Sci. 2018;22(11):3357\u201362.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3086_CR89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/GRF.0000000000000516","volume":"63","author":"J Bi","year":"2020","unstructured":"Bi J, Thiel KW, Litman JM, Zhang Y, Devor EJ, Newtson AM, et al. Characterization of a TP53 somatic variant of unknown function from an ovarian cancer patient using organoid culture and computational modeling. Clin Obstet Gynecol. 2020;63(1):109\u201319.","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"3086_CR90","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","volume":"14","author":"N Maenhoudt","year":"2020","unstructured":"Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Rep. 2020;14(4):717\u201329.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"3086_CR91","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ygyno.2020.03.026","volume":"157","author":"H Chen","year":"2020","unstructured":"Chen H, Gotimer K, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS, et al. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020;157(3):783\u201392.","journal-title":"Gynecol Oncol"},{"key":"3086_CR92","doi-asserted-by":"publisher","first-page":"963689723118799","DOI":"10.1177\/09636897231187996","volume":"32","author":"Q Cao","year":"2023","unstructured":"Cao Q, Li L, Zhao Y, Wang C, Shi Y, Tao X, et al. PARPi decreased primary ovarian cancer organoid growth through early apoptosis and base excision repair pathway. Cell Transplant. 2023;32:9636897231187996.","journal-title":"Cell Transplant"},{"issue":"1","key":"3086_CR93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acsptsci.2c00200","volume":"6","author":"H Keles","year":"2023","unstructured":"Keles H, Schofield CA, Rannikmae H, Edwards EE, Mohamet L. A scalable 3D high-content imaging protocol for measuring a drug induced DNA damage response using immunofluorescent subnuclear \u03b3H2AX spots in patient derived ovarian cancer organoids. ACS Pharmacol Transl Sci. 2023;6(1):12\u201321.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"11","key":"3086_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107762","volume":"31","author":"CJ de Witte","year":"2020","unstructured":"de Witte CJ, Espejo Valle-Inclan J, Hami N, L\u00f5hmussaar K, Kopper O, Vreuls CPH, et al. Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses. Cell Rep. 2020;31(11): 107762.","journal-title":"Cell Rep"},{"issue":"1","key":"3086_CR95","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","volume":"10","author":"Y Nanki","year":"2020","unstructured":"Nanki Y, Chiyoda T, Hirasawa A, Ookubo A, Itoh M, Ueno M, et al. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing. Sci Rep. 2020;10(1):12581.","journal-title":"Sci Rep"},{"issue":"8","key":"3086_CR96","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/biomedicines9081021","volume":"9","author":"JW Gorski","year":"2021","unstructured":"Gorski JW, Zhang Z, McCorkle JR, DeJohn JM, Wang C, Miller RW, et al. Utilizing patient-derived epithelial ovarian cancer tumor organoids to predict carboplatin resistance. Biomedicines. 2021;9(8):1021.","journal-title":"Biomedicines"},{"key":"3086_CR97","doi-asserted-by":"publisher","first-page":"1135374","DOI":"10.3389\/fbioe.2023.1135374","volume":"11","author":"E Cavarzerani","year":"2023","unstructured":"Cavarzerani E, Caligiuri I, Bartoletti M, Canzonieri V, Rizzolio F. 3D dynamic cultures of HGSOC organoids to model innovative and standard therapies. Front Bioeng Biotechnol. 2023;11:1135374.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3086_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41698-023-00379-8","volume":"7","author":"HJ Gray","year":"2023","unstructured":"Gray HJ, Chatterjee P, Rosati R, Appleyard LR, Durenberger GJ, Diaz RL, et al. Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing. NPJ Precis Oncol. 2023;7(1):45.","journal-title":"NPJ Precis Oncol"},{"key":"3086_CR99","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/IJWH.S405010","volume":"15","author":"W Chen","year":"2023","unstructured":"Chen W, Fang PH, Zheng B, Liang Y, Mao Y, Jiang X, et al. Effective treatment for recurrent ovarian cancer guided by drug sensitivity from ascites-derived organoid: a case report. Int J Womens Health. 2023;15:1047\u201357.","journal-title":"Int J Womens Health"},{"key":"3086_CR100","doi-asserted-by":"publisher","first-page":"1267650","DOI":"10.3389\/fonc.2023.1267650","volume":"13","author":"M Al-Aloosi","year":"2023","unstructured":"Al-Aloosi M, Prechtl AM, Chatterjee P, Bernard B, Kemp CJ, Rosati R, et al. Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma. Front Oncol. 2023;13:1267650.","journal-title":"Front Oncol"},{"issue":"1","key":"3086_CR101","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-023-02682-5","volume":"42","author":"E Cesari","year":"2023","unstructured":"Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, et al. Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids. J Exp Clin Cancer Res. 2023;42(1):126.","journal-title":"J Exp Clin Cancer Res"},{"key":"3086_CR102","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jsat.2019.01.020","volume":"99","author":"M Symons","year":"2019","unstructured":"Symons M, Feeney GFX, Gallagher MR, Young RM, Connor JP. Machine learning vs addiction therapists: a pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medication. J Subst Abuse Treat. 2019;99:156\u201362.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"3086_CR103","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.soard.2019.08.553","volume":"15","author":"VR Mani","year":"2019","unstructured":"Mani VR, Kalabin A, Nwakanama C, Suman P, Ahmed L. Preoperative versus intraoperative diagnosis of hiatal hernia in bariatric population. Surg Obes Relat Dis. 2019;15(11):1949\u201355.","journal-title":"Surg Obes Relat Dis"},{"key":"3086_CR104","doi-asserted-by":"publisher","DOI":"10.1159\/000510595","author":"MF Young","year":"2021","unstructured":"Young MF, Ramakrishnan U. Maternal undernutrition before and during pregnancy and offspring health and development. Ann Nutr Metab. 2021. https:\/\/doi.org\/10.1159\/000510595.","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"3086_CR105","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-020-0123-0","volume":"5","author":"K Lu","year":"2020","unstructured":"Lu K, Li B, Zhang H, Xu Z, Song D, Gao L, et al. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2\/STAT3 pathway. Signal Transduct Target Ther. 2020;5(1):31.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3086_CR106","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/biom13060900","volume":"13","author":"FC Li","year":"2023","unstructured":"Li FC, Kishen A. 3D organoids for regenerative endodontics. Biomolecules. 2023;13(6):900.","journal-title":"Biomolecules"},{"issue":"2","key":"3086_CR107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.stem.2020.01.003","volume":"26","author":"JK Ichida","year":"2020","unstructured":"Ichida JK, Ko CP. Organoids develop motor skills: 3D human neuromuscular junctions. Cell Stem Cell. 2020;26(2):131\u20133.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"3086_CR108","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.trecan.2022.06.001","volume":"8","author":"V Dao","year":"2022","unstructured":"Dao V, Yuki K, Lo YH, Nakano M, Kuo CJ. Immune organoids: from tumor modeling to precision oncology. Trends Cancer. 2022;8(10):870\u201380.","journal-title":"Trends Cancer"},{"issue":"1","key":"3086_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10858-019-00296-8","volume":"74","author":"IM Robertson","year":"2020","unstructured":"Robertson IM, Klein BA, Sykes BD. Optimizing fluorine labelling for (19)F solid-state NMR in oriented biological systems. J Biomol NMR. 2020;74(1):1\u20137.","journal-title":"J Biomol NMR"},{"key":"3086_CR110","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.2147\/CMAR.S305046","volume":"13","author":"D Yu","year":"2021","unstructured":"Yu D, Wu X, Li X, Liu X, Jiang K, Zhao Q, et al. Development and external validation of safe discharge criteria after radical gastrectomy. Cancer Manag Res. 2021;13:5251\u201361.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"3086_CR111","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/10410236.2020.1846272","volume":"37","author":"PF Chang","year":"2022","unstructured":"Chang PF, Bazarova NN, Wethington E. How older adults with chronic pain manage social support interactions with mobile media. Health Commun. 2022;37(3):384\u201396.","journal-title":"Health Commun"},{"key":"3086_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2020.105029","volume":"146","author":"AA Raba","year":"2020","unstructured":"Raba AA, O\u2019Sullivan A, Miletin J. Prediction of the need for phototherapy during hospital stay in preterm infants by transcutaneous bilirubinometry. Early Human Dev. 2020;146: 105029.","journal-title":"Early Human Dev"},{"issue":"2","key":"3086_CR113","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00292-020-00856-y","volume":"41","author":"S Scheil-Bertram","year":"2020","unstructured":"Scheil-Bertram S, Wardelmann E. Report of the bone, joint, and soft tissue pathology working group\u202f: DGP conference on 4 june 2020. Der Pathol. 2020;41(2):178\u201380.","journal-title":"Der Pathol"},{"issue":"3","key":"3086_CR114","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ab.21952","volume":"47","author":"AE Falk","year":"2021","unstructured":"Falk AE, Stiles K, Krein IN, Lee SS. Parenting behavior and growth of child conduct problems: moderation by callous-unemotional traits. Aggress Behav. 2021;47(3):251\u20139.","journal-title":"Aggress Behav"},{"issue":"3","key":"3086_CR115","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/heapro\/daaa083","volume":"36","author":"KM Greaux","year":"2021","unstructured":"Greaux KM, de Vries NK, Bessems K, Harting J, van Assema P. Does partnership diversity in intersectoral policymaking matter for health promoting intervention packages\u2019 composition? A multiple-case study in the Netherlands. Health Promot Int. 2021;36(3):616\u201329.","journal-title":"Health Promot Int"},{"issue":"1","key":"3086_CR116","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/uog.22007","volume":"56","author":"MO Nyhus","year":"2020","unstructured":"Nyhus MO, Mathew S, Salvesen O, Salvesen KA, Stafne S, Volloyhaug I. Effect of preoperative pelvic floor muscle training on pelvic floor muscle contraction and symptomatic and anatomical pelvic organ prolapse after surgery: randomized controlled trial. Ultrasound Obstet Gynecol. 2020;56(1):28\u201336.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"21\u201322","key":"3086_CR117","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/hum.2020.006","volume":"31","author":"C Rossi","year":"2020","unstructured":"Rossi C, Lees M, Mehta V, Heikura T, Martin J, Zachary I, et al. Comparison of efficiency and function of vascular endothelial growth factor adenovirus vectors in endothelial cells for gene therapy of placental insufficiency. Hum Gene Ther. 2020;31(21\u201322):1190\u2013202.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"3086_CR118","first-page":"719","volume":"17","author":"J Zhang","year":"2019","unstructured":"Zhang J, Deng G, Qiao L, Luo H, Liu Q, Liang N, et al. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. Oncol Lett. 2019;17(1):719.","journal-title":"Oncol Lett"},{"issue":"5","key":"3086_CR119","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/hmg\/ddz316","volume":"29","author":"JG Gilet","year":"2020","unstructured":"Gilet JG, Ivanova EL, Trofimova D, Rudolf G, Meziane H, Broix L, et al. Conditional switching of KIF2A mutation provides new insights into cortical malformation pathogeny. Hum Mol Genet. 2020;29(5):766\u201384.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"3086_CR120","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1097\/TA.0000000000001886","volume":"84","author":"A Cameron","year":"2018","unstructured":"Cameron A, Erdogan M, Lanteigne S, Hetherington A, Green RS. Organ donation in trauma victims: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2018;84(6):994\u20131002.","journal-title":"J Trauma Acute Care Surg"},{"key":"3086_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.113027","volume":"211","author":"S Ma","year":"2021","unstructured":"Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, et al. Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3. Eur J Med Chem. 2021;211: 113027.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"3086_CR122","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1038\/s41396-019-0482-0","volume":"13","author":"JG Klinges","year":"2019","unstructured":"Klinges JG, Rosales SM, McMinds R, Shaver EC, Shantz AA, Peters EC, et al. Phylogenetic, genomic, and biogeographic characterization of a novel and ubiquitous marine invertebrate-associated Rickettsiales parasite, Candidatus Aquarickettsia rohweri, gen. nov., sp. nov. ISME J. 2019;13(12):2938\u201353.","journal-title":"ISME J"},{"key":"3086_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2019.114942","volume":"164","author":"H Wang","year":"2019","unstructured":"Wang H, Lu L, Chen X, Bian Y, Ren ZJ. Geochemical and microbial characterizations of flowback and produced water in three shale oil and gas plays in the central and western United States. Water Res. 2019;164: 114942.","journal-title":"Water Res"},{"issue":"4","key":"3086_CR124","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201905-1021OC","volume":"202","author":"CS Hall","year":"2020","unstructured":"Hall CS, Quirk JD, Goss CW, Lew D, Kozlowski J, Thomen RP, et al. Single-session bronchial thermoplasty guided by (129)Xe magnetic resonance imaging. A pilot randomized controlled clinical trial. Am J Respir Crit Care Med. 2020;202(4):524\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3086_CR125","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12929-019-0602-1","volume":"27","author":"YH Chang","year":"2020","unstructured":"Chang YH, Chu TY, Ding DC. Human fallopian tube epithelial cells exhibit stemness features, self-renewal capacity, and Wnt-related organoid formation. J Biomed Sci. 2020;27(1):32.","journal-title":"J Biomed Sci"},{"key":"3086_CR126","doi-asserted-by":"publisher","first-page":"963689723116021","DOI":"10.1177\/09636897231160216","volume":"32","author":"YH Chang","year":"2023","unstructured":"Chang YH, Wu KC, Harnod T, Ding DC. Comparison of the cost and effect of combined conditioned medium and conventional medium for fallopian tube organoid cultures. Cell Transplant. 2023;32:9636897231160216.","journal-title":"Cell Transplant"},{"issue":"15","key":"3086_CR127","doi-asserted-by":"publisher","first-page":"e2026804118","DOI":"10.1073\/pnas.2026804118","volume":"118","author":"CA Simintiras","year":"2021","unstructured":"Simintiras CA, Dhakal P, Ranjit C, Fitzgerald HC, Balboula AZ, Spencer TE. Capture and metabolomic analysis of the human endometrial epithelial organoid secretome. Proc Natl Acad Sci USA. 2021;118(15):e2026804118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3086_CR128","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.7150\/ijbs.69410","volume":"18","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xu D, Li Y, Lan J, Zhu Y, Cao J, et al. Organoid transplantation can improve reproductive prognosis by promoting endometrial repair in mice. Int J Biol Sci. 2022;18(6):2627\u201338.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"3086_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302340","volume":"11","author":"B Hu","year":"2024","unstructured":"Hu B, Wang R, Wu D, Long R, Fan J, Hu Z, et al. A promising new model: establishment of patient-derived organoid models covering HPV-related cervical pre-cancerous lesions and their cancers. Adv Sci (Weinh). 2024;11(12): e2302340.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-03086-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:46:33Z","timestamp":1737024393000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-03086-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3086"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-03086-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}